Explore more publications!

Press Releases

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
zSpace Reports Fourth Quarter and Full Year 2025 Financial Results
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
Ebadat Publishes First-of-Its-Kind Legal Guide for U.S. Investors in European Football
GEMI Investor Alert: Gemini Space Station Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misled on Strategic Direction: Levi & Korsinsky
Sungrow and Huawei Achieve AAA Rating in New PV InverterTech Bankability Report
Supported by significant progress in the financing of its industrial project in France, Carbios confirms its objective to build the Longlaville plant
DeFi Technologies Announces the Appointment of Jacob Lindberg as Chief Revenue Officer of Valour to Lead Nordic and European Expansion
Benzaldehyde Market Trends: Flavor, Fragrance & Pharma Applications Fuel Growth in Europe & Asia-Pacific
Atomic Clock Market Growth Outlook 2026–2036 Driven by Strategic Defense, Space, and Telecom Investments
Menopause Functional Food & Beverage Market : Rising Women’s Health Awareness in North America & Europe, with Nestlé,
Surplus & Imperfect Produce Retail Market : Sustainability Trends Drive Growth in Europe & North America
Paper Bags Market Forecast 2026-2036 | North America & Europe Demand Surge with Top Companies Mondi, Smurfit Kappa
EUROPEAN WAX BUYOUT UPDATE: Kaskela Law Firm Continues Investigation into Inherent Fairness of $5.80 Per Share Buyout Announcement and Encourages EWCZ Shareholders to Contact the Firm
XBP Global Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Tempest Reports Year End 2025 Financial Results and Provides Business Update
Kayrros Launches Nature Impact Platform to Transform Nature Risk Assessment in Finance
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
USA Rare Earth Reports Fourth Quarter and Full-Year 2025 Financial Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions